RaQualia Pharma, Jan-Mar (1Q) Ordinary Profit Turns to Loss
4579 RaQualia Pharma Inc. 【J-GAAP】
Earnings ReportRaQualia Pharma Inc. <4579> [TSE Growth] announced its financial results after the market closed on May 15th (15:30). The consolidated ordinary profit/loss for the first quarter of the fiscal year ending December 2026 (January to March) turned into a loss of 158 million yen (compared to a profit of 29 million yen in the same period last year).
In the most recent three-month period, from January to March (1Q), the operating profit/loss margin drastically worsened from 9.6% in the same period last year to -20.0%.
Kabutan News
Actual Performance and Financial Trends
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Progress Rate vs. First Half |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
648M | 44M | -77M | -78M | -3.6 | ー | May 15, 2024 | J-GAAP |
|
|
965M | 93M | 29M | -5M | -0.2 | ー | May 15, 2025 | J-GAAP |
|
|
801M | -160M | -158M | -225M | -8.8 | ー | May 15, 2026 | J-GAAP |
| YoY | -17.0% | － | － | -4,400.0% | -3,583.3% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
1,535M | -190M | -291M | -354M | -15.5 | 0 | Aug 14, 2025 | J-GAAP |
|
Guidance
Jan - Jun, 2026
|
ー | ー | ー | ー | － | 0 | Feb 13, 2026 | J-GAAP |
| YoY | － | － | － | － | － |
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Adj. Dividend |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
3,107M | -213M | -361M | -495M | -22.9 | 0 | Feb 14, 2025 | J-GAAP |
|
|
3,979M | 483M | 437M | 273M | 11.5 | 0 | Feb 13, 2026 | J-GAAP |
|
Guidance
Dec, 2026
|
3,980M | 165M | 86M | -63M | -2.4 | 0 | Feb 13, 2026 | J-GAAP |
| YoY | +0.0% | -65.8% | -80.3% | － | － |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit |
Ordinary Profit |
Net Profit |
Adj. EPS |
Operating Profit Margin |
Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
|
|
965M | 93M | 29M | -5M | -0.2 | 9.6 | May 15, 2025 | J-GAAP |
|
|
570M | -283M | -320M | -349M | -15.3 | -49.6 | Aug 14, 2025 | J-GAAP |
|
|
776M | -154M | -135M | -214M | -9.2 | -19.8 | Nov 14, 2025 | J-GAAP |
|
|
1,668M | 827M | 863M | 841M | 35.5 | 49.6 | Feb 13, 2026 | J-GAAP |
|
|
801M | -160M | -158M | -225M | -8.8 | -20.0 | May 15, 2026 | J-GAAP |
| YoY | -17.0% | － | － | -4,400.0% | -3,583.3% |
Related Articles
-
Cyfuse Biomedical, Jan-Mar (1Q) Ordinary Profit Loss Widens
Fri May 15, 2026 3:30 pm JST Earnings -
PIALA, Jan-Mar (1Q) Ordinary Profit Decreases by 74%, Exceeds First Half Plan
Fri May 15, 2026 3:30 pm JST Earnings -
Asia Air Survey, First Half Ordinary Profit Decreases by 12%, Exceeds Full-Year Plan
Fri May 15, 2026 3:30 pm JST Earnings -
Batonz, 6% Increase in Ordinary Profit, Update Record High for Second Consecutive Term
Fri May 15, 2026 3:30 pm JST Earnings -
BASE, Jan-Mar (1Q) Ordinary Profit Decreases by 9%
Fri May 15, 2026 3:30 pm JST Earnings -
PORT, 22% Increase in Net Income, Update Record High for Fifth Consecutive Term, Dividend Raised by 1 Yen
Fri May 15, 2026 3:30 pm JST Earnings -
TRE HOLDINGS, 70% Decrease in Ordinary Profit for The Current Fiscal Year
Fri May 15, 2026 3:30 pm JST Earnings -
TAZMO, Jan-Mar (1Q) Ordinary Profit Decreases by 84%
Fri May 15, 2026 3:30 pm JST Earnings -
L is B Corp, Jan-Mar (1Q) Ordinary Profit Increases by 26%
Fri May 15, 2026 3:30 pm JST Earnings -
GLC GROUP, Jan-Mar (1Q) Ordinary Profit Decreases by 86%
Fri May 15, 2026 3:30 pm JST Earnings